Demographic and Clinical Profile of Haemodialysis Patients with End-Stage Renal Disease in a Northern Nigerian Hospital: A Retrospective Analysis of Patterns and Outcomes
Main Article Content
Keywords
Chronic kidney disease, end-stage renal disease, dialysis, low-resource settings, global health, epidemiology, sub-Saharan Africa, healthcare access
Abstract
Background: Chronic kidney disease (CKD) is a global health challenge with increasing prevalence and substantial impacts on healthcare systems, particularly in low- and middle-income countries. Limited access to resources for managing CKD and end-stage renal disease (ESRD) in these regions exacerbates mortality and morbidity, highlighting the need for effective and accessible healthcare strategies. This study examines CKD prevalence, management practices, and outcomes across various populations, with a focus on the challenges faced in sub-Saharan Africa.
Methodology: This study utilized a retrospective, observational design to examine patient records from the haemodialysis unit at Yusuf Dantsoho Memorial General Hospital, Kaduna State, Nigeria. The research focused on the sociodemographic, clinical, and dialysis-related characteristics of patients who underwent haemodialysis between January 2019 and October 2024.
Results: CKD prevalence has significantly increased worldwide, with ESRD incidence notably in our centre. Access to dialysis varied greatly, with low-resource settings struggling to meet demand, contributing to poorer outcomes. In Africa, studies show that less than 10% of patients who needed dialysis accessed it. Additionally, CKD patients in lower-income regions often present with advanced diseases due to inadequate screening and preventive care. High mortality rates were linked to limited access to early treatment and a lack of government support for subsidizing renal care.
Conclusion: There was a pressing need to improve CKD prevention, early diagnosis, and treatment in resource-limited settings to reduce the burden of ESRD. Increased government investment, enhanced screening programs, and sustainable funding models for dialysis were essential to mitigate the impact of CKD.
References
2. United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2020.
3. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013;382(9888):260-72.
4. Ulasi II, Ijoma CK. The enormity of chronic kidney disease in Nigeria: The situation in a teaching hospital in southeast Nigeria. J Trop Med. 2010;2010:501957.
5. Oluyombo R, Okunola OO, Olanrewaju TO, Okwuonu CG, Obajolowo AF, Soje MO, et al. Pattern of renal disease in elderly patients seen in a tertiary hospital in Nigeria. Trop J Nephrol. 2012;7(2):99-105.
6. Kaze FF, Ashuntantang G, Halle MP, Takongue C, Kengne AP. Acute hemodialysis complications in end-stage renal disease patients: The burden and implications for the under-resourced sub-Saharan African health systems. Hemodial Int. 2012;16(4):526-31.
7. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: A global challenge. Kidney Int Suppl. 2005;98.
8. Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido D, et al. Survival and development of cardiovascular risk factors in patients with hypertension and diabetes starting dialysis: A comparative analysis. Nephrol Dial Transplant. 2001;16(6):1188-95.
9. Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2003;61(3):61-3.
10. Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, et al. US Renal Data System 2010 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis. 2011;57(1 Suppl 1), e1-526.
11. United Kingdom Renal Registry. The 23rd Annual Report. Bristol: UKRR; 2021.
12. ERA-EDTA Registry. ERA-EDTA Registry 2020 Annual Report. Amsterdam: Academic Medical Center, Department of Medical Informatics; 2020.
13. Prasad N, Jha V. Hemodialysis in Asia. Kidney Dis. 2015;1(3):165-77.
14. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11(1):41-50.
15. Ulasi II, Ijoma CK, Onodugo OD. A community-based study of hypertension and cardiometabolic syndrome in semi-urban and rural communities in Nigeria. BMC Health Serv Res. 2010;10:71.
16. Okoye O, Nkombua L, Akinbo F. Health care utilization and costs in patients with kidney disease on haemodialysis in South Africa: A tertiary hospital experience. Afr J Prim Health Care Fam Med. 2015;7(1):1-6.
17. Kovesdy CP, Anderson JE, Collins AJ, Kalantar-Zadeh K. Age and outcomes associated with anemia in incident dialysis patients: A retrospective study. BMC Nephrol. 2010;11:11.
18. Kim H, Kim KH, Park K, Kang E, Lee H, Kim YL, et al. Changes in case mix and outcomes among elderly patients initiating dialysis over the past decade: A prospective cohort study. BMC Nephrol. 2018;19(1):11.
19. Arogundade FA. Kidney transplantation in a low-resource setting: Nigeria experience. Kidney Int Suppl. 2013;3(2):241-5.
20. Bamgboye EL. The challenges of ESRD care in developing economies: How do we get round the challenges? Int J Nephrol. 2011;2011:1-6.
21. Arogundade FA, Barsoum RS. CKD prevention in sub-Saharan Africa: A call for government, nongovernmental, and community support. Am J Kidney Dis. 2008;51(3):515-23.
22. Naicker S, Osuafor AM, Bopape M, Smit MP, Musenge E, Sola L, et al. Epidemiology of chronic kidney disease in South Africa: Results of a cross-sectional study. BMC Nephrol. 2015;16:128.
23. Porrini E, Ruggenenti P, Mogensen CE, Smulders YM, Parving HH, Tafuro S, et al. Management of diabetic nephropathy: Recommendations of the SENIOR group. Acta Diabetol. 2014;51(1):17-30.
24. Tsai HB, Chen YC, Hsu YH, Huang CC, Leu SC, Yeh JS, et al. Epidemiology and mortality of diabetic patients treated with dialysis: A Taiwan perspective. Int J Nephrol Renovasc Dis. 2015;8:7-14.
25. United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016.
26. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354(10):997-9.
27. Anochie IC, Eke FU, Okpere AN. Poor accessibility to kidney transplantation in developing countries: A Nigerian study. Saudi J Kidney Dis Transpl. 2008;19(2):228-32.
28. Yang CW, Harris DC, Luyckx VA, Nangaku M, Hou FF, Garcia GG, et al. Global case studies of chronic kidney disease. Clin Nephrol. 2017;88(1):99-106.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.